secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001683168-24-004667
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals announces $1.98M registered direct offering and private placement
--------------------------------------------------------------------------------

- Sold 1,425,000 shares at $1.39 per share with common warrants at $1.26 exercise price.
- Gross proceeds ~$1.98M; net proceeds for working capital and general corporate purposes.
- Closing expected July 5, 2024; warrants expire 5 years from issuance.
- A.G.P./Alliance Global Partners acting as financial advisor with 6.5% fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004667/0001683168-24-004667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004667/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer